These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30396366)

  • 1. Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy.
    Blessing MM; Blackburn PR; Balcom JR; Krishnan C; Harrod VL; Zimmermann MT; Barr Fritcher EG; Zysk CD; Jackson RA; Nair AA; Jenkins RB; Halling KC; Kipp BR; Ida CM
    Acta Neuropathol Commun; 2018 Nov; 6(1):118. PubMed ID: 30396366
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmoplastic non-infantile astrocytoma/ganglioglioma: rare low-grade tumor with frequent BRAF V600E mutation.
    Chatterjee D; Garg C; Singla N; Radotra BD
    Hum Pathol; 2018 Oct; 80():186-191. PubMed ID: 29902580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation.
    Greer A; Foreman NK; Donson A; Davies KD; Kleinschmidt-DeMasters BK
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27860162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma.
    Koelsche C; Sahm F; Paulus W; Mittelbronn M; Giangaspero F; Antonelli M; Meyer J; Lasitschka F; von Deimling A; Reuss D
    Neuropathol Appl Neurobiol; 2014 Apr; 40(3):337-44. PubMed ID: 23822828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations.
    Wang AC; Jones DTW; Abecassis IJ; Cole BL; Leary SES; Lockwood CM; Chavez L; Capper D; Korshunov A; Fallah A; Wang S; Ene C; Olson JM; Geyer JR; Holland EC; Lee A; Ellenbogen RG; Ojemann JG
    Mol Cancer Res; 2018 Oct; 16(10):1491-1498. PubMed ID: 30006355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas.
    Gessi M; Zur Mühlen A; Hammes J; Waha A; Denkhaus D; Pietsch T
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):807-15. PubMed ID: 23965740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
    Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
    Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Unusual Ganglioglioma with Pseudopapillary Features and PRKAR2B-BRAF Fusion.
    Oon ML; Low SYY; Kuick CH; Goh JY; Chang KTE; McLendon RE; Tan CL
    J Neuropathol Exp Neurol; 2021 Oct; 80(10):1000-1003. PubMed ID: 34599823
    [No Abstract]   [Full Text] [Related]  

  • 9. Unprecedented response to combination BRAF and MEK inhibitors in adult anaplastic ganglioglioma.
    Beland B; Tsang RY; Sutherland G
    J Neurooncol; 2018 May; 137(3):667-669. PubMed ID: 29335912
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report.
    Cicuendez M; Martinez-Saez E; Martinez-Ricarte F; Asanza EC; Sahuquillo J
    J Neurosurg Pediatr; 2016 Jul; 18(1):53-7. PubMed ID: 27015517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
    Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
    Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of BRAF status in glial and glioneuronal tumors: A systematic review.
    Sugiura Y; Nagaishi M
    J Clin Neurosci; 2019 Aug; 66():196-201. PubMed ID: 31147232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic landscape of ganglioglioma.
    Pekmezci M; Villanueva-Meyer JE; Goode B; Van Ziffle J; Onodera C; Grenert JP; Bastian BC; Chamyan G; Maher OM; Khatib Z; Kleinschmidt-DeMasters BK; Samuel D; Mueller S; Banerjee A; Clarke JL; Cooney T; Torkildson J; Gupta N; Theodosopoulos P; Chang EF; Berger M; Bollen AW; Perry A; Tihan T; Solomon DA
    Acta Neuropathol Commun; 2018 Jun; 6(1):47. PubMed ID: 29880043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent ganglioglioma in adults treated with BRAF inhibitors.
    Chamberlain MC
    CNS Oncol; 2016; 5(1):27-9. PubMed ID: 26680369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors.
    Koh HY; Kim SH; Jang J; Kim H; Han S; Lim JS; Son G; Choi J; Park BO; Heo WD; Han J; Lee HJ; Lee D; Kang HC; Shong M; Paik SB; Kim DS; Lee JH
    Nat Med; 2018 Nov; 24(11):1662-1668. PubMed ID: 30224756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare Activating BRAF Alteration Involving the β3-αC Kinase Domain in Ganglioglioma.
    Lin CC; Lefferts JA; Chan AM; Zanazzi G
    J Neuropathol Exp Neurol; 2021 Sep; 80(9):887-889. PubMed ID: 33611593
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant transformation of a desmoplastic infantile ganglioglioma in an infant carrier of a nonsynonymous TP53 mutation.
    Prakash V; Batanian JR; Guzman MA; Duncavage EJ; Geller TJ
    Pediatr Neurol; 2014 Jul; 51(1):138-43. PubMed ID: 24768217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of ganglioglioma to epithelioid glioblastoma, both with BRAF V600E mutation.
    Lau S; Clark J; Lokan J
    Pathology; 2022 Aug; 54(5):645-647. PubMed ID: 34895740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atypical ganglioglioma with BRAF V600E mutation: a case report and review of the literature].
    Martinez-Ricarte F; Martinez-Saez E; Cicuendez M; Cordero E; Auger C; Toledo M; Radoi A; Sahuquillo J
    Rev Neurol; 2016 May; 62(10):455-9. PubMed ID: 27149188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF V600E-Mutated Ganglioglioma of the Optic Pathway: A Case Report and Review of the Literature.
    Solomon AM; Chia TMT; Juric-Sekhar G; Francis CE
    J Neuroophthalmol; 2021 Dec; 41(4):e723-e727. PubMed ID: 33394641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.